Arcus Biosciences Inc (RCUS) — Capital Reinvestment Ratio
Latest as of September 2024:
0.04x
Arcus Biosciences Inc (RCUS) has a Capital Reinvestment Ratio of 0.04x as of September 2024, meaning it reinvests 0% of its operating cash flow ($26.00 Million) in capital expenditures ($1.00 Million). See Arcus Biosciences Inc free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.04x
Capex / Operating Cash Flow
Operating Cash Flow
$26.00 Million
USD
Capital Expenditures
$1.00 Million
USD
Data as of
Sep 2024
Most recent filing
Arcus Biosciences Inc Capital Reinvestment Ratio (2020–2022)
This chart tracks Arcus Biosciences Inc's Capital Reinvestment Ratio across 2 annual periods.
Annual Capital Reinvestment Ratio for Arcus Biosciences Inc (2020–2022)
Year-by-year Capital Reinvestment Ratio for Arcus Biosciences Inc from 2020 to 2022. For live market cap and broader valuation context, see Arcus Biosciences Inc market capitalisation.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 0.01x | $438.00 Million | $6.00 Million | ▼ -50.2% |
| 2020 | 0.03x | $111.17 Million | $3.06 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow